Press | About Synthace

Exploring key challenges in life science R&D

Technology Networks

What AI really means for biology and the pharmaceutical industry

Pharmaphorum

Synthace’s ‘Design of Experiments’ Approach Enables Multi-Factorial Wet Lab Experiments

BioIT World

Why experimental design is broken in biotech, and how to fix it

Data in Biotech Podcast

Listen now

How To Build a Data-Centric Future for Biotechnology

Technology Networks

Blending Biology and AI: Dr. Markus Gershater on the Future of Life Sciences

BiopharmaTrend.com

Synthace's New Report Reveals Challenges and Opportunities in Life Science R&D Experiments

Businesswire

Can ChatGPT be used to advance drug discovery?

Labiotech.eu

Synthace combines ChatGPT and digital experiments in first step toward a true AI scientist

Businesswire

Medtech innovators take gold at the Edison Awards

MDO

Synthace wins gold in the digital transformation category at Edison Awards

Edison Awards

Bio-IT World Names 2023 Innovative Practices Winners

Bio-IT World

Synthace, a Digital Experiment Platform for Life Science R&D, Records Strongest Year Yet

Businesswire

How design of experiments lowers costs in R&D

Scientific Computing World

5 reasons why collaboration is important in research

Labiotech

Innovative Product Solutions Introduced at SLAS 2023

Lab Manager

Iron Man vs Vision - The Value of Transparent AI

European Biopharmaceutical Review

2023: make or break for life science computing

Scientific Computing World

29 cutting-edge medtech innovations recognized with Edison Awards

Medical Design & Outsourcing

AI and experiments: new possibilities emerge in 2023

Labiotech.eu

How Design of Experiments enriches life sciences’ findings

Pharmaphorum

UK Silicon Valley plans are ‘antiquated and misguided’

ITPro

AI for Science: Dreams of Progress

Codon

In 2023, Scientists Go Beyond Lab Software to Improve Scientific Outcomes

Labcompare

How a US Recession Could Affect Biopharma

BioSpace

Why a Holistic Approach May Drastically Change the Way Experiments Are Conducted

Bio IT World

Synthace shortlisted for FT Tech Champions 2022

Financial Times

Labs and Computing Power: The Missing Link for a Revolution by 2030

Pharmaceutical Executive

How Digital Tools and Automation are Transforming Life Science R&D

Lab Manager

Hiding in plain sight: how to solve bioscience’s software problem

Labiotech.eu

Defining the future of experiment design

Bioscience Today

The Many Hats of a Biologist

Labcompare

Automation, AI and advancing the adjacent possible

Drug Discovery World

Synthace Appoints Dr. Donald Deieso as New Board Chair

Businesswire

Synthace Appoints Dr. Donald Deieso as New Board Chair

Yahoo! Finance

Appointments and advancements for Sept. 6, 2022

Bioworld

Meet Guy Levy-Yurista, CEO at Leading Biotech Scaleup: Synthace

Techround

What digitalization in biology R&D means for biotech companies and life scientists

Nature

We Need Biology in the Fight Against Climate Change. But Are We Ready To Use It?

Technology Networks

Cloud labs: where robots do the research

Nature

Executive Q&A with CEO Guy Levy-Yurista of Sythnace

Technology Magazine

Science Ventures Series: UK start-ups & later-stage fundraising

UKISSF

Cloud Computing Can Help Life Sciences Catch Up Before Itâ€™s Too Late

Labiotech.eu

How CDMOs Will Lead the Way Towards True Cloud Lab Enablement

Pharmeceutical Commerce

Enabling Life Sciences

Scientist Live

Seeing double: the rise of digital twins in life sciences

PharmaPhorum

Bringing Bioprocess Data Together

Gen newsletter

Phenotypeca announces commencement of â€˜Lab 4.0â€™ Project

Instrumental Business Outlook

Phenotypeca Announces Commencement of Lab 4.0 Project

We are Pioneering Group

Lab 4.0 project kicks off

Scientist Live

Four bioscience predictions for 2022

Scientific Computing

Biosciences in 2022: Bioscience Reaps Benefits From the Cloud

Technology Networks

European start-ups using AI in healthcare the new rage for venture capitalists

MSN

Synthace, Kick ICT and Hadrian Garner Funding

Eweek UK

Synthace Raises $35 Million to Expand Access to R&D Technology

Biopharm International

Synthace Raises $35M to Expand Access to Its Revolutionary R&D Technology for Life Changing Research

BusinessWire

UK's Synthace raises $35M in Series C

Endpoints News

Synthace bags US$35m for R&D cloud platform

European Biotechnology

Synthace raises $35m to expand access to its R&D tech platform

Evening Standard

Synthace Raises $35M in Series C Funding

Finsmes

Synthace raises $35m to expand access to its R&D tech platform

London Evening Standard

R&D-as-a-service model breathes new life into synthetic biology revolution, says GlobalData

MarketScreener

Synthaceâ€“SEVERAL: investment, 202111 financing round Series C $35m co-led by Sofinnova Partners + Horizon Ventures

Life-Sciences-Asia

Synthace Raises $35M to Expand Access to Its Revolutionary R&D Technology for Life Changing Research

MarketWatch

Synthace raises $35M Series C to accelerate the development of cures and expand reach

MobihealthNews

Laboratory Equipment and Instruments

Pharmaceutical Technology

European AI healthtechs cash in as investors bet big on sector

Sifted

Life Sciences R&D Startup Synthace Raises $35 Million to Help Scientists to Innovate Faster

Start-up Savant

Synthace Raises $35M to Expand Access to Its Revolutionary R&D Technology for Life Changing Research

SynBioBeta

Synthace raises $35 million, helps scientists automate biology experimentation and insight sharing

Tech.EU

Synthace Ltd.. (11/16/21). "Press Release: Synthace Raises $35M to Expand Access to Its Revolutionary R&D Technology for Life Changing Research". London & Boston, MA.

Life Sciences Germany

Synthace raises $35 million, helps scientists automate biology experimentation and insight sharing

Tech.EU

Synthace Raises $35M to Expand Access to Its R&D Technology for Research

TechnologyNetworks

Synthace Raises $35M to Expand Access to Its Revolutionary R&D Technology for Life Changing Research

Torchsec

Synthace Raises $35M to Expand Access to Its Revolutionary R&D Technology for Life Changing Research

Yahoo News

Follow the Money: Cloud R&D, Generative Biology, Robotics

Bio-IT World

$35M: Series C for Next-Gen R&D Cloud Platform

Clinical Research News

Synthace in the news

No results found.

Exploring key challenges in life science R&D

What AI really means for biology and the pharmaceutical industry

Synthace’s ‘Design of Experiments’ Approach Enables Multi-Factorial Wet Lab Experiments

Why experimental design is broken in biotech, and how to fix it

How To Build a Data-Centric Future for Biotechnology

Blending Biology and AI: Dr. Markus Gershater on the Future of Life Sciences

Synthace's New Report Reveals Challenges and Opportunities in Life Science R&D Experiments

Can ChatGPT be used to advance drug discovery?

Synthace combines ChatGPT and digital experiments in first step toward a true AI scientist

Medtech innovators take gold at the Edison Awards

Synthace wins gold in the digital transformation category at Edison Awards

Bio-IT World Names 2023 Innovative Practices Winners

Synthace, a Digital Experiment Platform for Life Science R&D, Records Strongest Year Yet

How design of experiments lowers costs in R&D

5 reasons why collaboration is important in research

Innovative Product Solutions Introduced at SLAS 2023

Iron Man vs Vision - The Value of Transparent AI

2023: make or break for life science computing

29 cutting-edge medtech innovations recognized with Edison Awards

AI and experiments: new possibilities emerge in 2023

How Design of Experiments enriches life sciences’ findings

UK Silicon Valley plans are ‘antiquated and misguided’

AI for Science: Dreams of Progress

In 2023, Scientists Go Beyond Lab Software to Improve Scientific Outcomes

How a US Recession Could Affect Biopharma

Why a Holistic Approach May Drastically Change the Way Experiments Are Conducted

Synthace shortlisted for FT Tech Champions 2022

Labs and Computing Power: The Missing Link for a Revolution by 2030

How Digital Tools and Automation are Transforming Life Science R&D

Hiding in plain sight: how to solve bioscience’s software problem

Defining the future of experiment design

The Many Hats of a Biologist

Automation, AI and advancing the adjacent possible

Synthace Appoints Dr. Donald Deieso as New Board Chair

Synthace Appoints Dr. Donald Deieso as New Board Chair

Appointments and advancements for Sept. 6, 2022

Meet Guy Levy-Yurista, CEO at Leading Biotech Scaleup: Synthace

What digitalization in biology R&D means for biotech companies and life scientists

We Need Biology in the Fight Against Climate Change. But Are We Ready To Use It?

Cloud labs: where robots do the research

Executive Q&A with CEO Guy Levy-Yurista of Sythnace

Science Ventures Series: UK start-ups & later-stage fundraising

Cloud Computing Can Help Life Sciences Catch Up Before Itâ€™s Too Late

How CDMOs Will Lead the Way Towards True Cloud Lab Enablement

Enabling Life Sciences

Seeing double: the rise of digital twins in life sciences

Bringing Bioprocess Data Together

Phenotypeca announces commencement of â€˜Lab 4.0â€™ Project

Phenotypeca Announces Commencement of Lab 4.0 Project

Lab 4.0 project kicks off

Four bioscience predictions for 2022

Biosciences in 2022: Bioscience Reaps Benefits From the Cloud

European start-ups using AI in healthcare the new rage for venture capitalists

Synthace, Kick ICT and Hadrian Garner Funding

Synthace Raises $35 Million to Expand Access to R&D Technology

Synthace Raises $35M to Expand Access to Its Revolutionary R&D Technology for Life Changing Research

UK's Synthace raises $35M in Series C

Synthace bags US$35m for R&D cloud platform

Synthace raises $35m to expand access to its R&D tech platform

Synthace Raises $35M in Series C Funding

Synthace raises $35m to expand access to its R&D tech platform

R&D-as-a-service model breathes new life into synthetic biology revolution, says GlobalData

Synthaceâ€“SEVERAL: investment, 202111 financing round Series C $35m co-led by Sofinnova Partners + Horizon Ventures

Synthace Raises $35M to Expand Access to Its Revolutionary R&D Technology for Life Changing Research

Synthace raises $35M Series C to accelerate the development of cures and expand reach

Laboratory Equipment and Instruments

European AI healthtechs cash in as investors bet big on sector

Life Sciences R&D Startup Synthace Raises $35 Million to Help Scientists to Innovate Faster

Synthace Raises $35M to Expand Access to Its Revolutionary R&D Technology for Life Changing Research

Synthace raises $35 million, helps scientists automate biology experimentation and insight sharing

Synthace Ltd.. (11/16/21). "Press Release: Synthace Raises $35M to Expand Access to Its Revolutionary R&D Technology for Life Changing Research". London & Boston, MA.

Synthace raises $35 million, helps scientists automate biology experimentation and insight sharing

Synthace Raises $35M to Expand Access to Its R&D Technology for Research

Synthace Raises $35M to Expand Access to Its Revolutionary R&D Technology for Life Changing Research

Synthace Raises $35M to Expand Access to Its Revolutionary R&D Technology for Life Changing Research

Follow the Money: Cloud R&D, Generative Biology, Robotics

$35M: Series C for Next-Gen R&D Cloud Platform

Synthace
in the news